FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Gomez-Zepeda, David; Arnold-Schild, Danielle; Beyrle, Julian et al.
Thunder-DDA-PASEF enables high-coverage immunopeptidomics and is boosted by MS<SUP>2</SUP>Rescore with MS<SUP>2</SUP>PIP timsTOF fragmentation prediction modelNATURE COMMUNICATIONS. Bd. 15. H. 1. 2024
Lampropoulou, Eleni; Benz, Claus; Kahaly, George J. et al.
Thyroid Inflammation and Immunity During the COVID-19 Pandemic: A Comprehensive Review and Case StudyHORMONE AND METABOLIC RESEARCH. Bd. 56. H. 02. 2024 S. 111-117
Betz, Ulrich; Clarius, Michael; Krieger, Manfred et al.
Time-Dependent Prediction Models for Individual Prognosis of Chronic Postsurgical Pain following Knee Replacement Based on an Extensive Multivariable Data SetJOURNAL OF CLINICAL MEDICINE. Bd. 13. H. 3. 2024
Clemens, V.; Jarczok, M.; Fegert, J. M. et al.
Timing and chronicity of child maltreatment in Germany: results from a representative samplePUBLIC HEALTH. Bd. 235. 2024 S. 173-179
Staubach, Petra; Tachdjian, Raffi; Li, H. Henry et al.
Timing of Onset of Garadacimab for Preventing Hereditary Angioedema AttacksCLINICAL AND EXPERIMENTAL ALLERGY. Bd. 54. H. 12. 2024 S. 1020-1023
Cruz-Correa, Marcia; Xu, Rui-Hua; Moehler, Markus H. et al.
Tislelizumab (TIS) plus chemotherapy (Chemo) vs placebo (PBO) plus chemo as first-line (1L) treatment of advanced gastric or gastroesophageal junction adenocarcinoma (GC/GEJC): Health-related quality of life (HRQoL) outcomes in the RATIONALE-305 study.JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 3_SUPPL. 2024 S. 290-290
Arkenau, Hendrik-Tobias; Tabernero, Josep; Cruz-Correa, Marcia et al.
Tislelizumab plus chemotherapy (chemo) versus placebo plus chemo as first-line treatment for locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma: RATIONALE-305 European/North American patient subgroup.JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 3_SUPPL. 2024 S. 330-330
Qiu, Miao-Zhen; Oh, Do-Youn; Kato, Ken et al.
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trialBMJ-BRITISH MEDICAL JOURNAL. Bd. 385. 2024
Broker, Vanessa; Koetsier, Jarno J. J.; Thomassen, Stella et al.
Tissue Factor Pathway Inhibitor Modulates Endothelial and Vascular Smooth Muscle Cell Functions By Drifting Cellular PhenotypesBLOOD. Bd. 144. 2024 S. 3987-3988
da Costa Filho, Pio Moerbeck; Marcantonio, Camila Chierici; de Oliveira, Diego Pedreira et al.
Titanium micro-nano textured surface with strontium incorporation improves osseointegration: an <i>in vivo</i> and<i> in vitro</i> studyJOURNAL OF APPLIED ORAL SCIENCE. Bd. 32. 2024